The antibody-based delivery of interleukin-12 to solid tumors boosts NK and CD8+ T cell activity and synergizes with immune checkpoint inhibitors.
Int J Cancer
; 146(9): 2518-2530, 2020 05 01.
Article
in En
| MEDLINE
| ID: mdl-31374124
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Killer Cells, Natural
/
Colonic Neoplasms
/
Interleukin-12
/
CD8-Positive T-Lymphocytes
/
Drug Synergism
/
Antineoplastic Agents, Immunological
/
Antibodies, Monoclonal
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Int J Cancer
Year:
2020
Document type:
Article
Affiliation country:
Switzerland
Country of publication:
United States